A Taiwanese cohort used an exposure category that should not be relabeled as a result for one benzodiazepine.
What the exposure category contained
The retrospective study examined women with insomnia and mood-related diagnoses in insurance records. Sleep medication, including benzodiazepine and nonbenzodiazepine hypnotics, was associated with subsequent breast cancer, with an adjusted hazard ratio of 1.23 in the reported analysis.
That estimate applies to the study’s combined exposure definition. It is not a separately established effect for diazepam, alprazolam, or every benzodiazepine.
Underlying illness and detection may matter
Insomnia, treatment indication, healthcare use, and unmeasured risk factors can influence both prescribing and diagnosis. Claims record prescriptions and diagnoses rather than confirmed consumption or a biological cancer mechanism.
For evidentiary use, preserve the exposure category and relative-risk interpretation. The paper cannot establish individual causation or show that a specific sleep medicine produced a tumor. It supports a qualified observational association that requires careful attention to comparator and confounding.
Source paper
Original analysis of the supplied journal article, identified as PMC8542844.
Leave a Reply